As a member of Sg2’s Intelligence team, Josh contributes to the development of cardiovascular intelligence by evaluating the impact of emerging trends and technologies on care delivery. He helps develop Sg2’s cardiovascular offerings, including publications, educational events and analytical tools. He also is active in working with Sg2’s life science and supply partners.

Prior to joining Sg2, Josh received a PhD in neurobiology from the University of Chicago, where he studied the application of data analytics in understanding how oligodendrocytes function. In his graduate research, Josh leveraged genomics technologies to identify novel proteins involved in development to provide tools for the study of multiple sclerosis. He previously earned a BA in neurobiology from Macalester College and is a member of their local alumni association.

Josh has published his work in several international scientific journals and has also presented at numerous national and international conferences. In his spare time, he enjoys participating in his book club, learning to cook and traveling.